Skip to main content
Caplight Logo









Cellarity

Cellarity

Private
Somerville, MassachusettsHealthcare & Life Scienceshttps://cellarity.com/

Last Round

Series C

Oct 4, 2022

Est. Valuation

$621M

Total Funding Raised

$274M

Company Overview

Cellarity is a biotechnology company that develops oral therapeutics by utilizing an artificial intelligence platform to study and correct whole cell-state dysfunction.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

drug discoveryAI drug discoverycell state modulationin silico drug discoverytoxicogenomicsdrug safety predictionsingle-cell analysisAI biotechtherapeutic developmentcomputational biologypredictive toxicologymachine learning biologybiotech platformdrug discovery AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellarity Comparables

Compare Cellarity with similar companies based on industry and business-model similarity.

Cellarity comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Valo Health
84%
Iambic Therapeutics
82%
Insitro
81%

Cellarity Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series COct 4, 2022
Series BFeb 25, 2021
Series ADec 10, 2019

Cellarity Investors

Notable investors and investment history

Cellarity investors
InvestorRounds
Pictet GroupSeries B
JIMCOSeries B
Flagship PioneeringSeries C, Series B, Series A
BlackRockSeries B
Hanwha ImpactSeries C
The Baupost GroupSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 4, 2025

    Two oral presentations at the 67th ASH Annual Meeting.

  • May 12, 2025

    Ted Myles appointed as the new Chief Executive Officer.

Cellarity Filings

Explore SEC and related filing metadata, where available.

Cellarity filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cellarity's valuation, stock price, and market status.

Is Cellarity a public or private company?

Cellarity is a private company.

What is the current stock price of Cellarity?

Cellarity is a private company with no public stock price. No recent secondary market data is available.

How much is Cellarity worth (valuation)?

Cellarity's valuation is estimated at $621.0M based on funding round data.

Can I buy Cellarity stock?

Cellarity shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cellarity's last funding round?

Cellarity's most recent funding round was Series C on October 4, 2022.

Who are the main investors in Cellarity?

Key investors in Cellarity include Pictet Group, Flagship Pioneering, BlackRock, The Baupost Group.

Will Cellarity IPO soon?

No public IPO plans have been announced for Cellarity.

How can I track Cellarity secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cellarity's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSomerville, Massachusetts
Employee Range55
Year Founded2017
Last FundingOct 4, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?